Expert Perspective on Treating Hepatitis B Now and in the Future

This video capture of a plenary presentation from the 2019 CCO Hepatitis Annual Meeting reviews the HBV life cycle, discusses current strategies for managing chronic hepatitis B, and highlights emerging data on novel therapeutics that may soon affect practice.
Ira M. Jacobson, MD
Program Director
Paul Y. Kwo, MD
Released: June 27, 2019 Expiration: No longer available for credit

Related Content

Grace Wong, MD: use of an interactive decision support tool to guide screening for and treatment of HDV, from Clinical Care Options (CCO)

Grace LH Wong, MD Released: September 12, 2022

Dr Paul Kwo discusses evolving treatment options for hepatitis delta virus (HDV), from Clinical Care Options (CCO)

Paul Y. Kwo, MD Released: August 2, 2022

Download slides reviewing the latest data and guidance on approaches to managing patients with hepatitis delta virus (HDV), from Clinical Care Options (CCO)

person default Joseph (Patient) Maria Buti, MD person default Richard H. Davis, PA-C Robert G. Gish, MD Nancy Reau, MD Stefan Zeuzem, MD Released: July 25, 2022

Dr Nancy Reau on exciting viral hepatitis data from EASL 2022, including HBV, HDV (hepatitis delta), and HCV, from Clinical Care Options (CCO)

Nancy Reau, MD Released: July 13, 2022
Provided by the Annenberg Center for Health Sciences at Eisenhower
ACHS Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Gilead Sciences
Janssen Therapeutics
Merck & Co., Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings